Product
Bone Marrow Cell Transplant
1 clinical trial
18 indications
Indication
Acute Myeloid LeukemiaIndication
Acute Lymphocytic LeukemiaIndication
Biphenotypic Acute LeukemiaIndication
Prolymphocytic LeukemiaIndication
Chronic Myelogenous LeukemiaIndication
Plasma Cell LeukemiaIndication
Myelodysplastic SyndromesIndication
LeukemiaIndication
myeloidIndication
Burkitt lymphomaIndication
Relapsed T-Cell LymphomaIndication
Chronic Lymphocytic LeukemiaIndication
Small Lymphocytic LymphomaIndication
Marginal Zone LymphomaIndication
Follicular LymphomaIndication
Myeloproliferative NeoplasmIndication
MyelofibrosisClinical trial
Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning (RIC) With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological DiseasesStatus: Recruiting, Estimated PCD: 2027-10-22